Sales In China Likely To Grow By 20 Percent, Bayer AG Exec Says
This article was originally published in PharmAsia News
Executive Summary
China is seen by German drug maker Bayer AG as a source for one of its largest sales growths in another country, possibly increasing by more than 20 percent over the next five years